Thursday 29 December 2016

Antimicrobial Resistance and Antimicrobial Stewardship



Antibiotics are a type of antimicrobial that are used in treatment and prevention of bacterial infections. They may kill or inhibit the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as common cold or influenza, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics. Antibiotic resistance invoke especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock raising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance.

Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobial (including antibiotics), improves outcomes for patients, reduces microbial resistance, and reduces the spread of infections caused by multi-drug resistant organisms.

The abuse of antimicrobial is one of the most pressing public health problems in the world. Infectious organisms adapt to antimicrobial designed to kill them, making medicines ineffective. People infected with antimicrobial resistant organisms are more likely to have longer and more expensive hospital stays and may be more likely to die as a result of infection.




Wednesday 28 December 2016

In today’s economic climate your business decisions are as crucial as ever. 15th International Pharmaceutical Microbiology and Biotechnology Conference allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services.

15th International Pharmaceutical Microbiology and Biotechnology Conference is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in .

Premium Sponsorship Packages:




Lots of thoughts were put together planning to make this conference a premier event. Our worldwide Editorial Board Members of Journal of Microbial and Biochemical Technology, Journal of Plant Pathology and Microbiology and Clinical Microbiology: Open Access have agreed to promote and support the event.

Exhibiting at 15th International Pharmaceutical Microbiology and Biotechnology Conference will attain you with an exceptional format in showcasing your products and services. Conference Series Ltd Conferences and Exhibitions provide you one location to reach your top customers.

Always keep smiling :-)


Tuesday 27 December 2016

Conference Series LLC, with its international reputation is contributing its services to the scientific world by organizing more than 600 Plus International Conferences across the world. With the overwhelming success of previous annual Applied Microbiology Conference, Conference Series LLC officially welcomes entire scientific community to attend the 15th International Pharmaceutical Microbiology and Biotechnology Conference, during June 21-23, 2017 at London, UK.

Biotechnology 2017 is scheduled with a vision of promoting the field of Biotechnology, is going to play its own role in the development of applicability of Pharmaceuticals as there will be an integration of outstanding and ingenious scientists with enthusiastic graduates from all the related fields. Microbiology is the branch of Science, Specifically biology dealing with the study of Micro-organisms, or life too small to be seen with the naked eye.



Group Discounts: 4 or more members from the same lab/institute/university (or) anyone who wish to attend Conference is eligible to get special benefits from Conference Series Ltd
Please contact us.


Friday 23 December 2016

Biomedical Engineering:



Biomedical engineering (BME) is the application of engineering principles and design concepts to medicine and biology for healthcare purposes (e.g. diagnostic or therapeutic). This field seeks to close the gap between engineering and medicine, combining the design and problem solving skills of engineering with medical and biological sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Biomedical engineering has only recently emerged as its own study, compared to many other engineering fields. Such an evolution is common as a new field transitions from being an interdisciplinary specialization among already-established fields, to being considered a field in itself. Much of the work in biomedical engineering consists of research and development, spanning a broad array of sub-fields. Prominent biomedical engineering applications include the development of bio-compatible prostheses, various diagnostic and therapeutic medical devices ranging from clinical equipment to micro-implants, common imaging equipment such as MRIs and EEGs, regenerative tissue growth, pharmaceutical drugs and therapeutic biological.


Subtracks:

For more details, please visit: Biotechnology 2017

Keep smiling always :-)

Wednesday 21 December 2016


Special Session
Call for Special Session Chair:
To extend the influence of the conference, researchers within the field of the conference are invited to be the Special Session Chair.
To be the Special Session Chair, you can propose issues (subjects, topics) yourself for the parallel sessions and invite speakers as well as participants related to the area. The organizing committee will fully support the promotion of the conference.
Benefits:
To be the Special Session Chair, you can enjoy:

  • A free platform for academic exchanges;
  • Free dinners and coffee break during conference period; 
  • Free registration and accommodation(2 nights during the conference period)

PS: All attendees invited by the Special Session Chair can enjoy the maximum discount.
Duty:
To be the Special Session Chair, you should:
Determine the session topic within the conference field;
Invite scholars (no less than 10 attendees in one special session);
Host the meeting.
For more information, get back to me at: pharmaceutical@microbiologyconferences.org

Keep smiling always :-)

Thursday 15 December 2016



Antibiotics, also known as antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They can kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as colds or flu, and their inappropriate use allows the emergence of resistant organisms. In 1928, Alexander Fleming identified penicillin, the first chemical compound with antibiotic properties. Fleming was working on a culture of pathogenic bacteria when he noticed the spores of a small green mussel (Penicillium chrysogenum) in one of his culture plates. He observed that the presence of the mold killed or prevented the growth of bacteria.

Subtracks


Friday 11 November 2016

Global Congress

Pharma Microbiology 2017 is scheduled with a vision of promoting the field of Pharmaceutical Microbiology, is going to play its own role in the development of applicability of Pharmaceuticals as there will be an integration of outstanding and ingenious scientists with enthusiastic graduates from all the related fields. Microbiology is the branch of Science, Specifically biology dealing with the study of Micro-organisms, or life too small to be seen with the naked eye.
Set to take place on 19st and 20th June 2017, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential insights into the latest advancements in practice and technology, developments in regulation and the global harmonisation of evolving microbiology methods.
Join us as we ask questions such as, what are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms?
Hear presentations from an array of market leaders such as GSK, Genzyme, Abbott, Med Immune and AstraZeneca, address real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms.
Pharma/BioTech companies face challenge on how to improve quality of the safety data which is ever increasing in its quantity. Other challenges include managing the dynamic regulatory requirements, etc. which industries and the regulatory authorities face on a regular basis. In this setup, we are looking at communication and networking as important tools that can help industries and departments design new strategies to overcome the several implications.
Top key speakers include:
                    Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
                    Ruth Daniels, Head of MSAT, Microbiology, Genzyme
                    Sara Gamberini, Molecular Biology Scientist, Merck Serono
                    Hans Noordergraaf, Microbiologist, Abbott Biologicals
                    Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
                    Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
                    Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline

                    Phil Duncanson, Director of QC, MedImmune